//php print_r(get_the_ID()); ?>
Context:
Indian drugmakers Serum Institute of India and Panacea Biotec have submitted their responses to the Indian Council of Medical Research (ICMR) for an Expression of Interest (EOI) to collaborate on Phase 3 clinical trials for India’s first dengue vaccine.
About Dengue:
News Source: The Hindu
To get PDF version, Please click on "Print PDF" button.
Scheme to Promote Manufacturing of Electric Passen...
Ladakh’s New Rules on Quota, Domicile and Hill C...
First Fusion-Fission Hybrid Reactor: China Unveils...
Legislatures Enacting Laws Not Contempt of Court: ...
ICRISAT Centre of Excellence for South-South Coope...
World Air Transport Summit 2025 Key Highlights
<div class="new-fform">
</div>